Healthcare & Life Sciences
CytoDel
seed
seed
Stage
1
Investors
About
CytoDel produces recombinant derivatives of botulinum neurotoxin customized for specific applications using molecular biology techniques.
Explore CytoDel's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.